Mainstream

Pediatrix raises 2025 adjusted ebitda guidance to $245m–$255m as nicu days climb 6% and cash flow strengthens

Pediatrix raises 2025 adjusted EBITDA guidance to $245M–$255M as NICU days climb 6% and cash flow strengthens

Pediatrix raises 2025 adjusted EBITDA guidance to $245M–$255M as NICU days climb 6% and cash flow strengthens

Post ContentmdRead More

You might also be interested in reading Gemini legal team accuses DCG of ‘gaslighting’ Genesis creditors.

August 5, 2025
In Mainstream